180 related articles for article (PubMed ID: 2901486)
1. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
2. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
Long JB; Petras JM; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
[TBL] [Abstract][Full Text] [Related]
3. Antinociception and paralysis induced by intrathecal dynorphin A.
Herman BH; Goldstein A
J Pharmacol Exp Ther; 1985 Jan; 232(1):27-32. PubMed ID: 2856940
[TBL] [Abstract][Full Text] [Related]
4. Neurologic deficits and neuronal injury in rats resulting from nonopioid actions of the delta opioid receptor antagonist ICI 174864.
Long JB; Petras JM; Holaday JW
J Pharmacol Exp Ther; 1988 Mar; 244(3):1169-77. PubMed ID: 2908046
[TBL] [Abstract][Full Text] [Related]
5. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal dynorphin A (1-13) and (3-13) reduce spinal cord blood flow by non-opioid mechanisms.
Long JB; Kinney RC; Malcolm DS; Graeber GM; Holaday JW
NIDA Res Monogr; 1986; 75():524-6. PubMed ID: 2893280
[TBL] [Abstract][Full Text] [Related]
7. Effects of synchronous or asynchronous electroacupuncture stimulation with low versus high frequency on spinal opioid release and tail flick nociception.
Wang Y; Zhang Y; Wang W; Cao Y; Han JS
Exp Neurol; 2005 Mar; 192(1):156-62. PubMed ID: 15698629
[TBL] [Abstract][Full Text] [Related]
8. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
9. Influence of dynorphin (1-13) on spinal reflexes in the rat.
Caudle RM; Isaac L
J Pharmacol Exp Ther; 1988 Aug; 246(2):508-13. PubMed ID: 2900326
[TBL] [Abstract][Full Text] [Related]
10. Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration.
Hemstapat K; Le L; Edwards SR; Smith MT
Pharmacol Biochem Behav; 2009 Oct; 93(4):498-505. PubMed ID: 19580825
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
Tseng LF; Cheng SS; Fujimoto JM
J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
[TBL] [Abstract][Full Text] [Related]
12. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
Faden AI; Jacobs TP
Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
[TBL] [Abstract][Full Text] [Related]
13. [Intrathecal co-administration of kappa opioid receptor agonists and NMDA receptor antagonists induces synergistic analgesia in rats].
Li FC; Sun XJ; Hu WH; Jen MF
Yao Xue Xue Bao; 1994; 29(12):881-6. PubMed ID: 7709739
[TBL] [Abstract][Full Text] [Related]
14. Arginine8-vasopressin reduces spinal cord blood flow after spinal subarachnoid injection in rats.
Long JB; Martinez-Arizala A; Johnson SH; Holaday JW
J Pharmacol Exp Ther; 1989 May; 249(2):499-506. PubMed ID: 2524587
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between motor paralysis and neurotoxicity induced by intrathecal dynorphin A (1-17) in rats].
Cui CL; Wu LZ; Han JS
Yao Xue Xue Bao; 1997; 32(2):85-9. PubMed ID: 11243205
[TBL] [Abstract][Full Text] [Related]
16. Nonopioid motor effects of dynorphin A and related peptides: structure dependence and role of the N-methyl-D-aspartate receptor.
Shukla VK; Prasad JA; Lemaire S
J Pharmacol Exp Ther; 1997 Nov; 283(2):604-10. PubMed ID: 9353375
[TBL] [Abstract][Full Text] [Related]
17. Distinguishable effects of intrathecal dynorphins, somatostatin, neurotensin and s-calcitonin on nociception and motor function in the rat.
Spampinato S; Romualdi P; Candeletti S; Cavicchini E; Ferri S
Pain; 1988 Oct; 35(1):95-104. PubMed ID: 2904671
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal somatostatin in rats: antinociception only in the presence of toxic effects.
Gaumann DM; Yaksh TL
Anesthesiology; 1988 May; 68(5):733-42. PubMed ID: 2897175
[TBL] [Abstract][Full Text] [Related]
19. Hindlimb paralytic effects of arginine vasopressin and related peptides following spinal subarachnoid injection in the rat.
Long JB; Martinez-Arizala A; Rigamonti DD; Holaday JW
Peptides; 1988; 9(6):1335-44. PubMed ID: 3247252
[TBL] [Abstract][Full Text] [Related]
20. Proenkephalin A fragments exhibit spinal and supraspinal opioid activity in vivo.
Dray A; Nunan L; Wire W
J Pharmacol Exp Ther; 1985 Dec; 235(3):670-6. PubMed ID: 3001272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
